New treatment paths for Breast Cancer

#Breast #cancer is a common illness around the world. It is the most common invasive of #cancers in #women and affects around one in eight and represents about a quarter of all invasive cancers.

Immunotherapies that take off the "brakes" on the adaptive anti-tumor response have worked well in #melanoma and #lung_cancer but less so in breast cancers. In general breast cancer #tumors harbor a decreased presence of tumor-infiltrating lymphocytes and have been considered poor candidates for triggering an immune response. The research team, however, activated innate #immunity in breast cancer cells and the tumor microenvironment by testing the use of a synthetic #RIG-I agonist in breast cancer cells and in a mouse model of breast cancer. RIG-I, or retinoic acid-inducible gene I, is a virus-sensing receptor that activates pro-inflammatory signaling pathways.

A research team in India well aware of the issues, costs and discomfort surrounding screening and assessment of breast tumors with conventional #mammography have developed a novel system for monitoring changes in such a tumor that uses a compact #micro_strip #antenna. Such devices are relatively easy to fabricate and have a wide range of more conventional applications in the world of #telecommunications as #satellite television receivers and such. The team describes details in the International Journal of Biomedical Engineering and Technology and explains how the devices comprise a radiating patch with a rectangular slot, three stubs, a feed-line and a partial ground plane. The devices operate at a frequency of between 2.4 and 4.76 gigahertz and measure the resonance of the tumour, as opposed to healthy breast, tissue, which have different dielectric properties.

For more details please follow the link: https://frontiersmeetings.com/conferences/breastcancercongress/

For queries and details contact us: breastcancer@globalbreastcancercongress.org